Hey everyone! Hope you’re all having a great week so far.
Check out the latest episode of the SMA News Today Podcast here. In this roundtable discussion, Michael and I talk about several recent news stories and columns. The first story we look at is about how risdiplam is enhancing the motor function of people with SMA types 2 and 3. We share our thoughts about what this could mean for adults with SMA in the future.
We then discuss a more controversial story about AveXis putting its STRONG trial on temporary hold. Michael and I address some of the misconceptions surrounding this news, and we share our thoughts.
SMA News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.